NCT00022399View on ClinicalTrials.gov

Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 25, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Prostate Cancer
Interventions
DRUG

celecoxib

400mg PO twice daily for 4-6 weeks up to 8 hours prior to prostatectomy.

DRUG

Placebos

Placebo PO twice daily for 4-6 weeks up to 8 hours prior to prostatectomy.

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00022399 - Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer | Biotech Hunter | Biotech Hunter